{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:26:55Z","timestamp":1780417615625,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1124\/dmd.115.067173","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T04:04:12Z","timestamp":1449720252000},"page":"250-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Application of Micropatterned Cocultured Hepatocytes to Evaluate the Inductive Potential and Degradation Rate of Major Xenobiotic Metabolizing Enzymes"],"prefix":"10.1016","volume":"44","author":[{"given":"Vaishali","family":"Dixit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niresh","family":"Hariparsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.067173_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/microarrays4010064","article-title":"3D Cultivation Techniques for Primary Human Hepatocytes","volume":"4","author":"Bachmann","year":"2015","journal-title":"Microarrays"},{"key":"10.1124\/dmd.115.067173_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fasebj.10.13.8940293","article-title":"Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: hepatocytes cultured in a sandwich configuration","volume":"10","author":"Berthiaume","year":"1996","journal-title":"FASEB J"},{"key":"10.1124\/dmd.115.067173_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.041186","article-title":"Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells \u2018feel\u2019 outside and in?","volume":"123","author":"Buxboim","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1124\/dmd.115.067173_bib3","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1124\/dmd.113.053397","article-title":"Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac","volume":"41","author":"Chan","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2174\/138920009789375397","article-title":"The transcriptional regulation of the human CYP2C genes","volume":"10","author":"Chen","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.115.067173_bib5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1124\/dmd.107.016089","article-title":"Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions","volume":"35","author":"Dixit","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/clpt.2013.170","article-title":"Evaluation of various static and dynamic modeling methods to predict clinical CYP3A induction using in vitro CYP3A4 mRNA induction data","volume":"95","author":"Einolf","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.067173_bib7","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1124\/dmd.110.033126","article-title":"Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes","volume":"38","author":"Fahmi","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/jpet.105.098160","article-title":"Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor","volume":"317","author":"Faucette","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.067173_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.067173_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2125.2012.04345.x","article-title":"The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers","volume":"75","author":"Garg","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.115.067173_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","article-title":"Clinical relevance of genetic polymorphisms in the human CYP2C subfamily","volume":"52","author":"Goldstein","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.115.067173_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-4652(199812)177:4<553::AID-JCP6>3.0.CO;2-F","article-title":"Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix","volume":"177","author":"G\u00f3mez-Lech\u00f3n","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1124\/dmd.115.067173_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/dmd.106.009290","article-title":"Drug-drug interaction between pitavastatin and various drugs via OATP1B1","volume":"34","author":"Hirano","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2125.2008.03120.x","article-title":"The recovery time-course of CYP3A after induction by St John\u2019s wort administration","volume":"65","author":"Imai","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.115.067173_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01874052","article-title":"Fluorescence in situ hybridization analysis of chromosomal localization of three human cytochrome P450 2C genes (CYP2C8, 2C9, and 2C10) at 10q24.1","volume":"39","author":"Inoue","year":"1994","journal-title":"Jpn J Hum Genet"},{"key":"10.1124\/dmd.115.067173_bib17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/clpt.2011.59","article-title":"Sensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction","volume":"90","author":"Kharasch","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.067173_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.115.067173_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1345\/aph.17456","article-title":"Potential interaction involving warfarin and ritonavir","volume":"32","author":"Knoell","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.115.067173_bib20","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/mp2003658","article-title":"New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists","volume":"8","author":"K\u00fcblbeck","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.115.067173_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.clpt.6100431","article-title":"Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin","volume":"84","author":"Magnusson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.067173_bib23","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.115.067173_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.fpc.0000215070.52212.0e","article-title":"Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin","volume":"16","author":"Niemi","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.115.067173_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/dmd.113.055947","article-title":"Generating an in vitro-in vivo correlation for metabolism and liver enrichment of a hepatitis C virus drug, faldaprevir, using a rat hepatocyte model (HepatoPac)","volume":"42","author":"Ramsden","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/dmd.115.065326","article-title":"Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac","volume":"43","author":"Ramsden","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/clpt.2010.271","article-title":"Rifampin\u2019s acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design","volume":"89","author":"Reitman","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.067173_bib28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0026-895X(24)12051-2","article-title":"Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices","volume":"28","author":"Renwick","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jbt.20264","article-title":"Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes","volume":"23","author":"Sahi","year":"2009","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.115.067173_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.115.067173_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1089\/adt.2013.525","article-title":"A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis","volume":"12","author":"Trask","year":"2014","journal-title":"Assay Drug Dev Technol"},{"key":"10.1124\/dmd.115.067173_bib33","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1124\/dmd.110.034876","article-title":"Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1124\/dmd.113.056804","article-title":"Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450","volume":"42","author":"Yajima","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/bpb.34.389","article-title":"Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes","volume":"34","author":"Yamaguchi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.115.067173_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/138920008784746382","article-title":"Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions","volume":"9","author":"Yang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.115.067173_bib37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1124\/dmd.114.057018","article-title":"Investigational small-molecule drug selectively suppresses constitutive CYP2B6 activity at the gene transcription level: physiologically based pharmacokinetic model assessment of clinical drug interaction risk","volume":"42","author":"Zamek-Gliszczynski","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1124\/dmd.114.058602","article-title":"Evaluation of calibration curve-based approaches to predict clinical inducers and noninducers of CYP3A4 with plated human hepatocytes","volume":"42","author":"Zhang","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.115.067173_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1872312808666140317153311","article-title":"Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytes","volume":"7","author":"Zhu","year":"2014","journal-title":"Drug Metab Lett"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624101547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624101547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.067173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:22:41Z","timestamp":1739906561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624101547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0090955624101547"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.067173","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Micropatterned Cocultured Hepatocytes to Evaluate the Inductive Potential and Degradation Rate of Major Xenobiotic Metabolizing Enzymes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.067173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}